Volume 20, Issue 9 pp. 1020-1025

A Prospective Randomized Study to Assess the Efficacy of Rate and Site of Atrial Pacing on Long-Term Development of Atrial Fibrillation

CHU-PAK LAU M.D.

CHU-PAK LAU M.D.

Queen Mary Hospital, University of Hong Kong, Hong Kong

Search for more papers by this author
CHUN-CHIEH WANG M.D.

CHUN-CHIEH WANG M.D.

Chang Gung Memorial Hospital, Linkou, Taiwan

Search for more papers by this author
TACHAPONG NGARMUKOS M.D.

TACHAPONG NGARMUKOS M.D.

Ramathibodi Hospital, Mahidol University, Bangkok, Thailand

Search for more papers by this author
YOU-HO KIM M.D.

YOU-HO KIM M.D.

Asan Medical Center, Korea

Search for more papers by this author
CHI-WOON KONG M.D.

CHI-WOON KONG M.D.

Taipei Veterans General Hospital, Taiwan

Search for more papers by this author
RAZALI OMAR M.D.

RAZALI OMAR M.D.

Institut Jantung Negara, Malaysia

Search for more papers by this author
CHARN SRIRATANASATHAVORN M.D.

CHARN SRIRATANASATHAVORN M.D.

Siriraj Hospital, Mahidol University, Bangkok, Thailand

Search for more papers by this author
MUHAMMAD MUNAWAR M.D.

MUHAMMAD MUNAWAR M.D.

Harapan Kita Hospital, Indonesia

Search for more papers by this author
RUTH KAM M.D.

RUTH KAM M.D.

Changi General Hospital, Singapore

Search for more papers by this author
KATHY LF LEE M.D.

KATHY LF LEE M.D.

Queen Mary Hospital, University of Hong Kong, Hong Kong

Search for more papers by this author
ELIZABETH OI-YAN LAU Ph.D.

ELIZABETH OI-YAN LAU Ph.D.

St. Jude Medical, Hong Kong

Search for more papers by this author
HUNG-FAT TSE M.D., Ph.D.

HUNG-FAT TSE M.D., Ph.D.

Queen Mary Hospital, University of Hong Kong, Hong Kong

Search for more papers by this author
SAFE Study Steering Committee for the SAFE Study Group

SAFE Study Steering Committee for the SAFE Study Group

The complete SAFE Study Group is listed in the Appendix 1.

Search for more papers by this author
First published: 26 August 2009
Citations: 9
Address for correspondence: Professor C.P. Lau, Director, Institute of Cardiovascular Science and Medicine, Honorary Professor in Medicine, Division of Cardiology, Department of Medicine, Room 1927, 19/F, Block K, Queen Mary Hospital, Pokfulam Road, Hong Kong. Fax: 852-2818-6304; E-mail: [email protected]

This study is supported by St. Jude Medical Inc.

Dr. Lau received funds to support the core lab; he also received travel support to an investigators’ meeting and holding shares of common stock in an unspecified company relevant to this topic. Dr. Wang served as a member of the steering committee of the SAFE study. Dr. Ngarmukos received financial support for travel to an investigators’ meeting. Drs. Kong and Omar served on the advisory board of the SAFE study. Dr. Kam received travel support from Medtronic International to present poster at a meeting and also served on the clinical advisory boards of St. Jude Medical and Medtronic International Inc.

Abstract

The Septal Pacing for Atrial Fibrillation Suppression Evaluation (SAFE) study is a single-blinded, parallel randomized designed multicenter study in pacemaker indicated patients with paroxysmal atrial fibrillation (AF). The objective is to evaluate whether the site of atrial pacing–-conventional right atrial appendage versus low atrial septal—with or without atrial overdrive pacing will influence the development of persistent AF. The study will provide a definitive answer to whether a different atrial pacing site or the use of AF suppression pacing or both can give incremental antiarrhythmic benefit when one is implanting a device for a patient with a history of paroxysmal AF.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.